NCT04728178

Brief Summary

To compare the goal-directed fluid therapy based on the data obtained from the hemodynamic monitoring system, which provides continuous CO, SV and SVV measurements through arterial pressure wave with standard fluid therapy in perioperative fluid management of patients undergoing head and neck surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

January 20, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 28, 2021

Completed
Last Updated

January 28, 2021

Status Verified

January 1, 2021

Enrollment Period

1.3 years

First QC Date

January 20, 2021

Last Update Submit

January 23, 2021

Conditions

Keywords

fluid therapyprolonged oxygen demandperioperative fluid balance

Outcome Measures

Primary Outcomes (1)

  • Intraoperative fluid balance

    the total and additional amount of crystalloid and colloid fluid fluid given during the surgery

    during surgery

Secondary Outcomes (9)

  • Prolonged IMV demand

    during 8 hours after surgery

  • Prolonged oxygen demand

    during 8 hours after surgery

  • Heart rate

    during surgery

  • Blood Pressure

    during surgery

  • hospitalisation time

    postoperative period (up to 6 weeks)

  • +4 more secondary outcomes

Study Arms (2)

study group

ACTIVE COMPARATOR

In the control group, fluid management was set as MAP (Mean arterial pressure) 65 mmHg and above and diuresis 0.5ml/kg/hour and above. Crystalloid infusion at 7ml/kg/hour was started. When SVV value increased to 13% and over in the study group, 250 ml of crystalloid was given in the first stage, and if it continued to be 13% and over, 250 ml of colloid bolus was given. Vasoconstrictor agent was used when SVV was below 13% and MAP was below 65 mmHg.

Other: Crystalloid solutionOther: Colloid solution

control group

PLACEBO COMPARATOR

In the control group, fluid management was set as MAP (Mean arterial pressure) 65 mmHg and above and diuresis 0.5ml/kg/hour and above. Crystalloid infusion at 7ml/kg/hour was started. They were given 250 ml of crystalloid in the first stage if the MAP was below 65 mmHg, and 250 ml of colloid bolus if the hypotensive episode continued. If hypotension persisted despite these fluid boluses, a vasoconstrictor agent was used. In addition, when the diuresis of the patients was detected at 0.5mg/kg/hr or less, 250 ml of colloid bolus was administered.

Other: Crystalloid solutionOther: Colloid solution

Interventions

Crystalloid solution is a true solution and is able to pass through a semipermeable membrane.

control groupstudy group

Colloid solution is a heterogeneous mixture whose particle size is intermediate between those of a solution and a suspension.

control groupstudy group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteering to participate in the study
  • ASA classification 1, 2 or 3
  • The patients who will undergo head and neck surgery

You may not qualify if:

  • Being under the age of 18 or over the age of 80
  • Presence of serious cardiac, renal and liver pathology ( ejection fraction\< %35 and/or glomerular filtration rate\< 30ml/kg/min, kreatinin\>2,5mg/dl and/or abnormal liver function test)
  • The patients who have heart rhythm problems such as atrial fibrillation, sinus tachycardia, ventricular extrasystoles
  • The patients who have a peripheral arterial disease
  • Being a morbid obese ( BMI\>40 kg/m2)
  • the patients who may have considered difficult airway

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University, Department of Anesthesiology

Istanbul, Fatih, 34093, Turkey (Türkiye)

Location

Related Publications (2)

  • Davies SJ, Minhas S, Wilson RJ, Yates D, Howell SJ. Comparison of stroke volume and fluid responsiveness measurements in commonly used technologies for goal-directed therapy. J Clin Anesth. 2013 Sep;25(6):466-74. doi: 10.1016/j.jclinane.2013.04.010. Epub 2013 Aug 17.

    PMID: 23965199BACKGROUND
  • Funk D, Bohn J, Mutch W, Hayakawa T, Buchel EW. Goal-directed fluid therapy for microvascular free flap reconstruction following mastectomy: A pilot study. Plast Surg (Oakv). 2015 Winter;23(4):231-4. doi: 10.4172/plastic-surgery.1000937.

    PMID: 26665136BACKGROUND

MeSH Terms

Interventions

Crystalloid Solutions

Intervention Hierarchy (Ancestors)

Isotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Demet Altun Bingol, Assoc. Prof.

    Istanbul University

    PRINCIPAL INVESTIGATOR
  • Nuray Turkut, MD

    Istanbul University

    PRINCIPAL INVESTIGATOR
  • Cansu Uzuntürk, Resident

    Istanbul University

    PRINCIPAL INVESTIGATOR
  • Emre Çamcı, Prof.

    Istanbul University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
attending anesthesiologist

Study Record Dates

First Submitted

January 20, 2021

First Posted

January 28, 2021

Study Start

October 1, 2017

Primary Completion

January 1, 2019

Study Completion

May 1, 2019

Last Updated

January 28, 2021

Record last verified: 2021-01

Locations